论文部分内容阅读
浙江大学医学院董辰方教授课题组发现,治疗糖尿病并发症的药物依帕司他能有效抑制乳腺癌细胞,该药物有望成为治疗致命性乳腺癌的有效靶向药物。相关论文发表于国际知名期刊《实验医学杂志》上。乳腺癌4种临床亚型中“三阴性乳腺癌”最具致命性,目前尚无有效治疗手段,患者得病后,癌细胞特别容易转移到脑、肺等器官,生存率极低。研究人员通过对5 000余例乳腺癌肿瘤样本的分析发现,三阴性乳腺癌细胞中“醛酮还
Zhejiang University School of Medicine Professor Dong Chenfang task force found that the treatment of diabetic complications drug epalrestat can effectively inhibit breast cancer cells, the drug is expected to become an effective target for the treatment of fatal breast cancer drugs. Related papers published in the international well-known journal ”Experimental Medicine Journal“ on. In the four clinical subtypes of breast cancer, ”triple negative breast cancer“ is the most lethal one. Currently, there is no effective treatment method. After the patients get sick, the cancer cells are particularly likely to be transferred to organs such as brain and lung with extremely low survival rate. Researchers through more than 5,000 cases of breast cancer tumor samples found that triple negative breast cancer cells, ”aldehyde and ketone also